In the fast-moving and competitive field of cybersecurity, certifications are one of the most effective ways to bolster your ...

The next generation of AI PCs is here! Neural processors help these cutting-edge Windows 11 laptops power Microsoft's ...

This month’s application period opened May 7 for the following positions: administrative real property manager; construction ...

Penetration tests of AI systems expose significantly higher severe-flaw density when compared to legacy apps. New attack ...

CSL shares are tumbling again on Wednesday. Here's what it'll take for the price to take a u-turn. You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing ...

Image for representation only. Andhra Pradesh is sto unveil India's first open-access quantum computer test beds that will allow researchers, startups and institutions to try out their systems and ...

CSL chief financial officer Ken Lim says the global healthcare giant is trying to simplify its organisation after conceding that a slowdown in its ability to make quick decisions had hurt its ...

After teasing a plasma-based manufacturing expansion in the U.S. late last year, CSL is putting in the work and firming up details behind the $1.5 billion project. Monday, the Australian biopharma ...

Illinois Gov. JB Pritzker on Monday announced a $1.5 billion investment from biotherapeutics company CSL for a new plasma therapy manufacturing plant in Kanakee. CSL will expand its current footprint ...

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. CSL has started construction ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Melbourne-based company will ...

New $1.5 billion investment builds on over $3 billion already spent on CSL's U.S. operations since 2018 Expansion will create at least 300 new jobs and enhance production of plasma-derived therapies ...